About

In addition, researchers are studying its ability to compete and antagonize testosterone in these tissues selectively. It exerts anabolic activity in muscle and connective tissue with little effect on the prostate and seminal vesicles. Yes, PCT is highly recommended after a RAD-140 cycle to help restore natural testosterone production and maintain gains. Also, it's essential to research and understand the potential interactions and side effects before combining any compounds. Yes, RAD-140 can be stacked with other SARMs or supplements to enhance its effects, although this isn’t really necessary due to RAD-140’s strength. It is essential to stick to the recommended dosage and cycle guidelines, implementing proper post-cycle therapy (PCT), and monitoring for any adverse reactions in order to minimize the risk of side effects.. Ostarine and LGD-4033, while still effective in promoting muscle growth, may not be as potent as RAD-140 in this regard.|To reap the recreational effects of Testolone without exposing yourself to any harm, we suggest you RadBulk by Brutal Force! However, considering its illegal nature and wide-range of side effects, we often question its safety adding to your overall satisfaction. Flash sales, exclusive deals, project discounts, and news delivered to your inbox. Selective androgen receptor modulator RAD-140 is neuroprotective in cultured neurons and kainate-lesioned male rats.|Preclinical data supports a favorable shift in body composition, though human data is limited. Strength gains are typically noticed within 2-4 weeks of starting a cycle. However, like all exogenous AR agonists, it suppresses endogenous testosterone production through negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis. Importantly, RAD-140 does not undergo aromatization to estrogen and is not a substrate for 5-alpha reductase, meaning it does not produce estrogenic or DHT-mediated side effects. At the molecular level, it activates AR-dependent gene transcription pathways involved in protein synthesis, nitrogen retention, and satellite cell proliferation in skeletal muscle.|A first-in-human phase 1 study of a novel selective androgen receptor modulator (SARM), RAD140, in ER+/HER2- metastatic breast cancer. MK-677 increases growth hormone and IGF-1 through ghrelin receptor agonism, complementing the AR-mediated anabolic effects of RAD-140. RAD-140 causes dose-dependent testosterone suppression typically visible by week 4-6, with users reporting 30-70% suppression by mid-cycle depending on dose and individual sensitivity. RAD-140's tissue selectivity means it stimulates muscle and bone more than prostate compared to testosterone, but it still suppresses testosterone and activates androgen receptors systemically.|For bodybuilders and athletes, this means RAD-140 is best used as a supplementary tool alongside testosterone, not a replacement. Worse, it still suppresses natural testosterone production, leaving users at risk of hormonal imbalance when taken without a test base. For this reason, athletes and bodybuilders use RAD-140 as a complement, not a substitute, for testosterone.|Similar to other Selective Androgenic Receptor Modulators, the synthetic ligand offers remedial effects for health-related problems. In addition to expanding size and activating fat loss momentum, RAD 140 is also known to upgrade the performance bar. Yes, according to the experts, they target the only androgenic receptors in the muscle and bones.|In terms of muscle hypertrophy (size) and strength, LGD-4033 and RAD-140 are similar in potency. In terms of the dosage and duration of a RAD-140 PCT protocol, below are a couple of sample cycles that bodybuilders use. However, its indirect impact on natural testosterone converting to DHT may be problematic for human users. In theory, RAD-140’s tissue selectivity should prevent any androgenic side effects, which are portrayed in animal research .}
RAD-140 does not replace testosterone; it only stimulates muscle tissue selectively. While RAD-140 avoids estrogen-related side effects like bloating and gynecomastia, it still suppresses natural testosterone and may strain the liver. This can leave users with low libido, fatigue, and hormonal imbalances once the cycle ends.
However, none can claim that RAD-140 or any other SARM safely substitutes the use of steroids. Besides, there is no medically tested dosage validating any level of protection against its possible side effects. According to it, Testolone can weaken your vision while leading to liver failure. Therefore, it’s earlier to say if RAD 140 will ever receive a ‘clean chit’ in this matter! SARMs are investigational drugs and there is a need for more research to determine their actual potential. Thus, the cycle of SARM demands Post Cycle Therapy (PCT) for 4-6weeks to maintain your results.
Preclinical data supports the potential to preserve or restore muscle mass in catabolic states, but no human efficacy trials have been completed for this indication. Users report meaningful increases in lean mass over 8-12 week cycles at mg/day, though controlled human trial data for this indication is lacking. RAD-140 has demonstrated a high degree of tissue selectivity in preclinical models, with an anabolic-to-androgenic ratio substantially greater than that of testosterone. Medical research council grants have supported studies investigating its effects on muscle and bone health, though concerns about severe hepatotoxicity have been raised with prolonged or high-dose use.
Our female patients typically utilize 5–10 mg/day for a similar duration, enabling them to experience the benefits of RAD-140 without any virilizing (masculinizing) effects. However, we see male patients commonly take 10–20 mg/day for 6–12 weeks to enhance body composition. Such telogen effluvium is typically transient and does not result in long-term androgenetic alopecia (hormone-related hair loss) unless RAD-140 is abused. This user’s experience indicates that low dosages of RAD-140 may increase its reward-to-risk ratio, with the subject gaining 10 pounds and losing a noticeable amount of subcutaneous fat simultaneously.